Literature DB >> 11318540

Salivary growth factors and cytokines are not deficient in patients with gastroesophageal reflux disease or Barrett's esophagus.

K Kongara1, G Varilek, E E Soffer.   

Abstract

Growth factors, such as epidermal growth factor (EGF), are known to protect upper gut mucosa against irritants and to enhance healing of ulcerative lesions in animal models. A number of salivary growth factors are found in human saliva. The aim of this study was to determine if salivary growth factors and cytokines are deficient in patients with esophagitis or with Barrett's metaplasia. Fifteen healthy subjects, eight patients with esophagitis, and 13 patients with Barrett's metaplasia were included. Salivary concentration of EGF, FGF, IL-1, and IL-6 were measured during esophageal saline and hydrochloric acid perfusion and in the postprandial state. There was no statistically significant difference in the concentration of EGF or cytokines among the three study groups in each experimental condition or among the three experimental conditions in each group. FGF basic could not be detected in saliva. In conclusion, these findings do not support the hypothesis that a deficiency in salivary growth factors or cytokines plays a significant role in the development of mild to moderate reflux esophagitis or Barrett's metaplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318540     DOI: 10.1023/a:1005615703009

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Modulation of salivary secretion by acid infusion in the distal esophagus in humans.

Authors:  S K Dutta; H B Matossian; R F Meirowitz; J Vaeth
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

2.  Salivary and serum interleukin 6 in primary Sjögren's syndrome.

Authors:  M M Grisius; D K Bermudez; P C Fox
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

3.  Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis.

Authors:  S J Konturek; T Radecki; T Brzozowski; I Piastucki; A Dembiński; A Dembińska-Kieć; A Zmuda; R Gryglewski; H Gregory
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

4.  IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release.

Authors:  N Tanda; H Ohyama; M Yamakawa; M Ericsson; T Tsuji; J McBride; A Elovic; D T Wong; G R Login
Journal:  Am J Physiol       Date:  1998-01

5.  Distribution and release of epidermal growth factor in man.

Authors:  J W Konturek; W Bielanski; S J Konturek; J Bogdal; J Oleksy
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

6.  Relationship of medical status, medications, and salivary flow rates in adults of different ages.

Authors:  M Navazesh; V J Brightman; J M Pogoda
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-02

7.  Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.

Authors:  R M Rourk; Z Namiot; J Sarosiek; Z Yu; R W McCallum
Journal:  Am J Gastroenterol       Date:  1994-02       Impact factor: 10.864

8.  The localization of basic fibroblast growth factor (FGF-2) in rat submandibular glands.

Authors:  Y Hiramatsu; H Kagami; K Kosaki; T Shigetomi; M Ueda; S Kobayashi; M Sakanaka
Journal:  Nagoya J Med Sci       Date:  1994-12       Impact factor: 1.131

9.  The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat.

Authors:  J Sarosiek; T Feng; R W McCallum
Journal:  Am J Med Sci       Date:  1991-12       Impact factor: 2.378

Review 10.  Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update.

Authors:  U Marti; S J Burwen; A L Jones
Journal:  Hepatology       Date:  1989-01       Impact factor: 17.425

View more
  5 in total

1.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

2.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.

Authors:  Xiao-Jun Yang; Hong-Mei Jiang; Xiao-Hua Hou; Jun Song
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan.

Authors:  Ibrahim Warsi; Javeria Ahmed; Anjum Younus; Abdur Rasheed; Tayyab Saeed Akhtar; Qurrat Ul Ain; Zohaib Khurshid
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

4.  Gastroesophageal reflux disease and tooth erosion: SEPAHAN systematic review no. 10.

Authors:  Malih Sadat Firouzei; Saber Khazaei; Parastoo Afghari; Ghazal Savabi; Omid Savabi; Ammar Hassanzadeh Keshteli; Peyman Adibi
Journal:  Dent Res J (Isfahan)       Date:  2011-12

5.  Salivary transforming growth factor alpha in patients with Sjögren's syndrome and reflux laryngitis.

Authors:  Marco Antonio dos Anjos Corvo; Claudia Alessandra Eckley; Luis Vicente Rizzo; Luiz Roberto Sardinha; Tomas Navarro Rodriguez; Ivo Bussoloti Filho
Journal:  Braz J Otorhinolaryngol       Date:  2014-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.